Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
Utah Medical Products Inc. (UTMD), a developer of medical devices for clinical and acute care settings, is trading at a current price of $64.41 as of May 6, 2026, marking a 0.69% decline in the day’s session so far. This analysis, aligned with the latest public market analysis of UTMD’s stock performance, evaluates near-term technical levels, prevailing market context, and potential price scenarios for the stock, as no recent earnings data is available to drive company-specific fundamental senti
The fundamentals driving Utah (UTMD) everyone should understand (At Lows) 2026-05-06 - Technical Analysis
UTMD - Stock Analysis
4755 Comments
1322 Likes
1
Vairon
Returning User
2 hours ago
Who else is here just trying to learn?
👍 57
Reply
2
Yali
Regular Reader
5 hours ago
This feels like something I’ll regret later.
👍 178
Reply
3
Shundria
Registered User
1 day ago
Really regret not checking earlier. 😭
👍 234
Reply
4
Jasa
Power User
1 day ago
I don’t understand, but I feel involved.
👍 259
Reply
5
Jalaya
Legendary User
2 days ago
Useful for tracking market sentiment and momentum.
👍 77
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.